• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于深入了解唐氏综合征肥胖机制的通路水平信息提取器(PLIER)框架。

A Pathway-Level Information ExtractoR (PLIER) framework to gain mechanistic insights into obesity in Down syndrome.

作者信息

Nandi Sutanu, Zhu Yuehua, Gillenwater Lucas A, Subirana-Granés Marc, Zhang Haoyu, Janani Negar, Greene Casey, Pividori Milton, Chikina Maria, Costello James C

机构信息

Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA, School of Medicine, Tsinghua University, Beijing, China.

出版信息

Pac Symp Biocomput. 2025;30:412-425. doi: 10.1142/9789819807024_0030.

DOI:10.1142/9789819807024_0030
PMID:39670386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11649010/
Abstract

Down syndrome (DS), caused by the triplication of chromosome 21 (T21), is a prevalent genetic disorder with a higher incidence of obesity. Traditional approaches have struggled to differentiate T21-specific molecular dysregulation from general obesity-related processes. This study introduces the omni-PLIER framework, combining the Pathway-Level Information ExtractoR (PLIER) with the omnigenic model, to uncover molecular mechanisms underlying obesity in DS. The PLIER framework aligns gene expression data with biological pathways, facilitating the identification of relevant molecular patterns. Using RNA sequencing data from the Human Trisome Project, omni-PLIER identified latent variables (LVs) significantly associated with both T21 and body mass index (BMI). Elastic net regression and causal mediation analysis revealed LVs mediating the effect of karyotype on BMI. Notably, LVs involving glutathione peroxidase-1 (GPX1) and MCL1 apoptosis regulator, BCL2 family members emerged as crucial mediators. These findings provide insights into the molecular interplay between DS and obesity. The omni-PLIER model offers a robust methodological advancement for dissecting complex genetic disorders, with implications for understanding obesity-related processes in both DS and the general population.

摘要

唐氏综合征(DS)由21号染色体三体性(T21)引起,是一种常见的遗传性疾病,肥胖发生率较高。传统方法一直难以区分T21特异性分子失调与一般肥胖相关过程。本研究引入了全基因组多基因风险评分(omni-PLIER)框架,将通路水平信息提取器(PLIER)与全基因模型相结合,以揭示DS中肥胖的分子机制。PLIER框架将基因表达数据与生物通路对齐,有助于识别相关分子模式。利用来自人类三体项目的RNA测序数据,omni-PLIER识别出与T21和体重指数(BMI)均显著相关的潜在变量(LVs)。弹性网络回归和因果中介分析表明,LVs介导了核型对BMI的影响。值得注意的是,涉及谷胱甘肽过氧化物酶-1(GPX1)和MCL1凋亡调节因子、BCL2家族成员的LVs成为关键介质。这些发现为DS与肥胖之间的分子相互作用提供了见解。omni-PLIER模型为剖析复杂遗传疾病提供了强大的方法学进展,对理解DS和普通人群中与肥胖相关的过程具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94c/11649010/2eb7fc800e84/nihms-2038217-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94c/11649010/783a3dd6b386/nihms-2038217-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94c/11649010/07342f04d54c/nihms-2038217-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94c/11649010/4ad3cbdaa91c/nihms-2038217-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94c/11649010/e0e3f2d98d7f/nihms-2038217-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94c/11649010/2eb7fc800e84/nihms-2038217-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94c/11649010/783a3dd6b386/nihms-2038217-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94c/11649010/07342f04d54c/nihms-2038217-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94c/11649010/4ad3cbdaa91c/nihms-2038217-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94c/11649010/e0e3f2d98d7f/nihms-2038217-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a94c/11649010/2eb7fc800e84/nihms-2038217-f0005.jpg

相似文献

1
A Pathway-Level Information ExtractoR (PLIER) framework to gain mechanistic insights into obesity in Down syndrome.一种用于深入了解唐氏综合征肥胖机制的通路水平信息提取器(PLIER)框架。
Pac Symp Biocomput. 2025;30:412-425. doi: 10.1142/9789819807024_0030.
2
MousiPLIER: A Mouse Pathway-Level Information Extractor Model.MousiPLIER:一种基于小鼠通路水平的信息提取模型。
eNeuro. 2024 Jun 5;11(6). doi: 10.1523/ENEURO.0313-23.2024. Print 2024 Jun.
3
Identification of dysregulated microRNAs in lymphocytes from children with Down syndrome.鉴定唐氏综合征患儿淋巴细胞中失调的 microRNAs。
Gene. 2013 Nov 10;530(2):278-86. doi: 10.1016/j.gene.2013.07.055. Epub 2013 Aug 8.
4
Comprehensive investigation of DNA methylation and gene expression in trisomy 21 placenta.21三体综合征胎盘DNA甲基化和基因表达的综合研究。
Placenta. 2016 Jun;42:17-24. doi: 10.1016/j.placenta.2016.03.012. Epub 2016 Mar 24.
5
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors.21 三体通过增加干扰素受体的剂量激活犬尿氨酸途径。
Nat Commun. 2019 Oct 18;10(1):4766. doi: 10.1038/s41467-019-12739-9.
6
Pathways to cognitive deficits in Down syndrome.唐氏综合征认知缺陷的发生途径。
Prog Brain Res. 2012;197:73-100. doi: 10.1016/B978-0-444-54299-1.00005-4.
7
Pathway-level information extractor (PLIER) for gene expression data.用于基因表达数据的通路级别信息提取器(PLIER)。
Nat Methods. 2019 Jul;16(7):607-610. doi: 10.1038/s41592-019-0456-1. Epub 2019 Jun 27.
8
Genome-wide expression analysis in Down syndrome: insight into immunodeficiency.唐氏综合征的全基因组表达分析:对免疫缺陷的深入了解。
PLoS One. 2012;7(11):e49130. doi: 10.1371/journal.pone.0049130. Epub 2012 Nov 14.
9
Analysis of genotype effects and inter-individual variability in iPSC-derived trisomy 21 neural progenitor cells.诱导多能干细胞衍生的21三体神经祖细胞的基因型效应及个体间变异性分析。
Hum Mol Genet. 2025 Jan 23;34(1):85-100. doi: 10.1093/hmg/ddae160.
10
The transcriptome profile of human trisomy 21 blood cells.人类 21 三体血细胞的转录组图谱。
Hum Genomics. 2021 May 1;15(1):25. doi: 10.1186/s40246-021-00325-4.

引用本文的文献

1
GRACKLE: an interpretable matrix factorization approach for biomedical representation learning.GRACKLE:一种用于生物医学表示学习的可解释矩阵分解方法。
Bioinformatics. 2025 Jul 1;41(Supplement_1):i609-i618. doi: 10.1093/bioinformatics/btaf213.
2
PLIERv2: bigger, better and faster.PLIERv2:更大、更好、更快。
bioRxiv. 2025 Jun 8:2025.06.05.658122. doi: 10.1101/2025.06.05.658122.
3
Genetic Studies Through the Lens of Gene Networks.透过基因网络视角的遗传学研究。

本文引用的文献

1
A hybrid constrained continuous optimization approach for optimal causal discovery from biological data.一种用于从生物数据中进行最优因果发现的混合约束连续优化方法。
Bioinformatics. 2024 Sep 1;40(Suppl 2):ii87-ii97. doi: 10.1093/bioinformatics/btae411.
2
MousiPLIER: A Mouse Pathway-Level Information Extractor Model.MousiPLIER:一种基于小鼠通路水平的信息提取模型。
eNeuro. 2024 Jun 5;11(6). doi: 10.1523/ENEURO.0313-23.2024. Print 2024 Jun.
3
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia.
Annu Rev Biomed Data Sci. 2025 Feb 20. doi: 10.1146/annurev-biodatasci-103123-095355.
4
Genetic studies through the lens of gene networks.基于基因网络视角的遗传学研究。
ArXiv. 2024 Oct 30:arXiv:2410.23425v1.
ABCC1 和谷胱甘肽代谢限制了 BCL-2 抑制剂在急性髓系白血病中的疗效。
Nat Commun. 2023 Sep 19;14(1):5709. doi: 10.1038/s41467-023-41229-2.
4
The Gene Variants (rs1050450) in Obesity: Association with the Risk of Obesity and the GPx Activity in Females.肥胖中的基因变体(rs1050450):与肥胖风险及女性谷胱甘肽过氧化物酶活性的关联
Rep Biochem Mol Biol. 2023 Apr;12(1):185-194. doi: 10.52547/rbmb.12.1.185.
5
Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms.通过基因表达模式预测遗传关联,突出了疾病的病因和药物机制。
Nat Commun. 2023 Sep 9;14(1):5562. doi: 10.1038/s41467-023-41057-4.
6
Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition.唐氏综合征干扰素病的多维定义及其对 JAK 抑制的反应。
Sci Adv. 2023 Jun 28;9(26):eadg6218. doi: 10.1126/sciadv.adg6218.
7
Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model.干扰素受体基因座三倍体导致小鼠模型中唐氏综合征的特征。
Nat Genet. 2023 Jun;55(6):1034-1047. doi: 10.1038/s41588-023-01399-7. Epub 2023 Jun 5.
8
Dysregulated systemic metabolism in a Down syndrome mouse model.唐氏综合征小鼠模型中系统性代谢失调。
Mol Metab. 2023 Feb;68:101666. doi: 10.1016/j.molmet.2022.101666. Epub 2022 Dec 29.
9
Resistance to Obesity in SOD1 Deficient Mice with a High-Fat/High-Sucrose Diet.超氧化物歧化酶1缺乏的小鼠对高脂/高糖饮食的肥胖抵抗性
Antioxidants (Basel). 2022 Jul 19;11(7):1403. doi: 10.3390/antiox11071403.
10
The multiple mechanisms of MCL1 in the regulation of cell fate.MCL1 在调控细胞命运中的多重机制。
Commun Biol. 2021 Sep 2;4(1):1029. doi: 10.1038/s42003-021-02564-6.